Lotus Pharmaceuticals Inc (LTUS)

Currency in USD
0.01
0.00(0.00%)
Closed·
LTUS Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
LTUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.010.01
52 wk Range
0.000.01
Key Statistics
Prev. Close
0.01
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0-0.01
Volume
21.94K
Average Volume (3m)
52.47K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LTUS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell

Lotus Pharmaceuticals Inc Company Profile

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.

Employees
383

Compare LTUS to Peers and Sector

Metrics to compare
LTUS
Peers
Sector
Relationship
P/E Ratio
0.0x−0.5x−0.5x
PEG Ratio
0.000.010.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
0.0x1.6x3.3x
Upside (Analyst Target)
0.0%189.8%40.3%
Fair Value Upside
Unlock0.7%5.1%Unlock

Earnings

Latest Release
Nov 10, 2011
EPS / Forecast
0.04 / --
Revenue / Forecast
19.04M / --
EPS Revisions
Last 90 days

LTUS Income Statement

FAQ

What Stock Exchange Does Lotus Pharmaceuticals Trade On?

Lotus Pharmaceuticals is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Lotus Pharmaceuticals?

The stock symbol for Lotus Pharmaceuticals is "LTUS."

What Is the Lotus Pharmaceuticals Market Cap?

As of today, Lotus Pharmaceuticals market cap is 21.24M.

What Is Lotus Pharmaceuticals's Earnings Per Share (TTM)?

The Lotus Pharmaceuticals EPS (TTM) is 0.06.

From a Technical Analysis Perspective, Is LTUS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Lotus Pharmaceuticals Stock Split?

Lotus Pharmaceuticals has split 1 times.

How Many Employees Does Lotus Pharmaceuticals Have?

Lotus Pharmaceuticals has 383 employees.

What is the current trading status of Lotus Pharmaceuticals (LTUS)?

As of 17 Aug 2025, Lotus Pharmaceuticals (LTUS) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.00 to 0.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.